Fig. 5. Clinical photographs of patients 6 and 10

Slides:



Advertisements
Similar presentations
Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
Advertisements

Clinical Experience With Antibiotic Protocol & RSD N=22 Duration of treatment: 2-4 months Retrospective, open label, clinical trial Responses are based.
Adding SubtractingMultiplyingDividingMiscellaneous.
Acne Scars Clinical Results. Courtesy of Dr. Ullman BeforeAfter 6.5 months following the 3 rd treatment.
Date of download: 9/17/2016 From: Topical Treatment of Pressure Ulcers with Nerve Growth Factor: A Randomized Clinical Trial Ann Intern Med. 2003;139(8):
Figure 2. Case 1 clinical photographs
Fig. 2. Clinical images of near total improvement cases. (A) No
Fig. 5. Agmatine suppressed JNK and P38 MAPK phosphorylation after TBI
Fig. 2. Angiographic findings of a hyaluronic acid-injected patient
From: Estimating the Yearly Number of Eyes with Treatable Neovascular Age-Related Macular Degeneration Using a Direct Standardization Method and a Markov.
Extracorporeal Shock Wave Therapy Is Effective in the Treatment of Bone Marrow Edema of the Medial Compartment of the Knee: A Comparative Study Med Princ.
Fig. 2. Effects of Ang II on the p130Cas protein assayed by Western blotting. (A) The bands for p130Cas protein at 130 kDa are reduced by 10-7 M Ang II.
Fig. 3. ATME inhibits VEGF-induced invasion and tube formation of endothelial cells. (A) Effect of ATME on HUVEC invasion by using the Transwell culture.
Fig. 2. Comparative efficacy of thromboprophylaxis interventions in the prevention of deep vein thrombosis (DVT). (A) Estimated odds ratios (ORs) and 95%
(A) Scatter plot correlating the infant mortality rate and the K index
Fig. 1. Abnormalities on chest imaging of the patient
Fig. 1. (A) Treatment of narrow linear scars after thyroidectomy can be challenging. Treatment with a fractional laser damages the surrounding tissue due.
Fig. 2. Markov model of opportunistic examination group
Fig 3. Time trends for infant mortality rate and hazard ratio according to the deprivation quintiles. (A) Time trend for the infant mortality rate according.
Before and After: Patient Cases in Onychomycosis
Removal of forearm lentigines in dyschromatosis universalis hereditaria with a 755-nm Q-switched alexandrite laser  Yiming Li, MD, PhD, Li Li, MD, PhD 
Fig. 2. Mutational signature exposures in Taiwan HCCs and summary of AA signature mutations. Mutational signature exposures in Taiwan HCCs and summary.
Clinical and photographic assessment of lichen planopilaris treatment efficacy  Aline Donati, MD, Philipe Assouly, MD, Bruno Matard, MD, Corinne Jouanique,
Clinical testing of calcineurin inhibitors cyclosporine A and tacrolimus in autoimmune disorders Clinical testing of calcineurin inhibitors cyclosporine.
Fig. 4 Topical application of SAAP-148 ointment eradicates acute and established infections of MRSA and A. baumannii from the skin. Topical application.
Topical tacrolimus treatment for cicatricial pemphigoid*
Fig. 4. Geographic atrophy progression in CFI risk-allele carriers and risk-negative subpopulations after monthly lampalizumab treatment. Geographic atrophy.
Fig. 1. scRNA-seq applications in cancer medicine.
Topical tacrolimus for chronic actinic dermatitis
Fig. 1. MAHALO clinical trial flowchart.
Tacrolimus ointment in the treatment of dirty neck lesions in atopic dermatitis  Kayako Hira, MD, Yasushi Suga, MD, PhD, Tomoyuki Monma, Kouichi Mitsuishi,
Lawrence F. Eichenfield, MD, Lisa Beck, MD 
Fig. 3. The effects of DCA on hemodynamic and functional end points and their association with genetic factors (variants of the SIRT3 and UCP2 genes) that.
Adding with 9’s.
Adding with 10’s.
Successful use of a fractional 2940-nm laser in treating chronic, severe erosive pustular dermatosis of the scalp  Hailey E. Grubbs, BS, MS-IV, Chris.
Reversibility of Blue-Gray Cutaneous Discoloration From Amiodarone
Current experience in treating invasive zygomycosis with posaconazole
CD facilitates RCT in vivo and promotes urinary cholesterol excretion
Adding ____ + 10.
Olga Vornicova, MD, Gil Bar-Sela, MD  JAAD Case Reports 
Fig. 2. Illustration of the procedure for finding spatiotemporal regions correspoding to significant differences between conditions using nonparametric.
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Spontaneous resolution of advanced basal cell carcinoma after short-pulse treatment with hedgehog pathway inhibitor  Audrey A. Jacobsen, BA, John Strasswimmer,
Fig. 1. Placement of BIS and PLE electrodes
Efficacy of topical diphenylcyclopropenone maintenance treatment for patients with alopecia areata: A retrospective study  Sung Jay Choe, MD, Solam Lee,
Fig. 3. Improved clinical responses to CD19 CAR-T cell immunotherapy after Cy/Flu lymphodepletion. Improved clinical responses to CD19 CAR-T cell immunotherapy.
SLE deconvolution patient clusters and representative immune cell types (A), and distribution of patients by SLE deconvolution cluster and treatment group—all.
Fig. 2. One case of recurrence out of 12 adult patients with totally resected ependymomas without anaplastic pathology or postoperative adjuvant treatment.
Fig. 2. Transmission electron microscopic view of cornea
Fig. 5. Skin changes after cosmetic facial filler injections on the glabella and/or nasal dorsum. (A-C) Hyaluronic acid-injected patients have skin necrosis.
Fig. 1. Detection of circulating tumor DNA in CRPC patients.
Fig. 2. Quarterly trend of OAC prescription among patients with atrial fibrillation from HIRA-NPS between 2013 and Solid line = results of segmented.
Fig. 2. Comparison of endometrial glands in the decidua of EBV-infected (left) and EBV-uninfected (right) chorioamniotic membranes. EBER1 SISH (A), EBER1.
Supplementary Fig. 1. Histograms and probability density functions of the town-level numbers of population from the NHID of the National Health Insurance.
Fig. 2. Findings are compatible with rheumatoid arthritis (RA) on additional blood pool phase and bone phase of patients with RA. Increased blood pool.
Fig. 2. Mutational signature exposures in Taiwan HCCs and summary of AA signature mutations. Mutational signature exposures in Taiwan HCCs and summary.
Results of aneurysm treatment with flow modification only.
Number of patients treated at clinics that followed up fewer than 10 patients (2013–2016) or 20 patients (2012) and proportion of patients followed up.
Fig. 1. Angiographic findings of an autologous fat-injected patient
Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani  Erwin Suys, MD  Journal of the American Academy.
Fig. 1. Antituberculosis drug resistance rate (%) and pattern in sanatoria of North Korea: (A) patients (n = 489) in all sanatoria analyzed in this study,
Fig. 8. Scrotal reconstruction using an external pudendal perforator-based island flap. (A) A 29-yr-old patient has scrotal loss with buried testis. (B)
Fig. 11. Tailored reconstruction of the upper lip
Fig. 1 Fractional coverage of the mapping method used in this study.
Fig. 4. Selective external carotid artery angiogram
Fig. 1. Initial views of the 2 new browsing software packages
Fig. 3. Association between peak CTL019 expansion and response.
Volume 5, Issue 10, Pages (October 2019)
H & E = hematoxylin and eosin.
Presentation transcript:

Fig. 5. Clinical photographs of patients 6 and 10 Fig. 5.Clinical photographs of patients 6 and 10. These patients were treated with topical tacrolimus 0.1% for 6 months due to vacuolar degeneration of basal layer at initial work-up. Laser treatment was subsequently added. (A, D) Before treatment in patient 6 and 10, respectively. (B, E) Six months after topical tacrolimus 0.1%, same respective order. (C, F) Eighteen months after treatment (topical tacrolimus 0.1% 6 months followed by laser for 12 months), same respective order. Fig. 5.Clinical photographs of patients 6 and 10. These patients were treated with topical tacrolimus 0.1% for 6 months due to vacuolar degeneration of basal layer at initial work-up. Laser treatment was subsequently added. (A, D) Before treatment in patient 6 and 10, respectively. (B, E) Six months after topical tacrolimus 0.1%, same respective order. (C, F) Eighteen months after . . . J Korean Med Sci. 2016 Dec;31(12):2042-2050. https://doi.org/10.3346/jkms.2016.31.12.2042